Cutaneous silent period in ATTRv carriers: a possible early marker of nerve damage?
Authors:
- 9 August 2022
- journal article
- letter
- Published by Springer Nature in Neurological Sciences
- Vol. 43 (12) , 6979-6982
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 11 references indexed in Scilit:
- Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experienceNeurological Sciences, 2022
- Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot StudyGenes, 2021
- Cutaneous silent period in ulnar neuropathy at the elbowMuscle & Nerve, 2021
- Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervationNeurological Sciences, 2021
- Contribution of Skin Biopsy in Peripheral NeuropathiesBrain Sciences, 2020
- Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkersJournal of Neurology, 2020
- Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient CareTherapeutics and Clinical Risk Management, 2020
- Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers ofTTRgene mutations*Amyloid, 2019
- Cutaneous silent period recordings in demyelinating and axonal polyneuropathiesClinical Neurophysiology, 2015
- Cutaneous silent period in carpal tunnel syndromeMuscle & Nerve, 2006